Finding 1221265 (2024-005)

Material Weakness Repeat Finding
Requirement
AB
Questioned Costs
-
Year
2024
Accepted
2026-06-30

AI Summary

  • Core Issue: Lack of controls over invoice approval and disbursement for federal expenditures.
  • Impacted Requirements: Failure to comply with federal regulations on allowable costs and activities.
  • Recommended Follow-Up: Implement a robust system for invoice approval and ensure an audit trail is maintained using Bill.com.

Finding Text

2024-005 Significant Deficiency –Approval of Invoices Criteria and Condition: In order to stay in compliance with federal requirements for allowable activities/allowable costs, the Organization must maintain a system of controls over federal expenditures. During compliance and control testing for allowable cost/allowable activities, no support could be provided regarding approval of the invoice and related disbursement. Context: Controls over invoice approval and related disbursement could not be reviewed on any of the 14 invoice sample selections. Cause: Management did not have controls in place to maintain an audit trail for the approval process of cash disbursements of federal awards to vendors and suppliers. Effect: Internal controls over cash disbursements to vendors and suppliers could not be evaluated. Recommendation: Establish a system of controls to approve disbursements and maintain an audit trail. Views of Responsible Officials and Planned Corrective Action: Bill.com is the system now being used to approve disbursements and maintain an audit trail.

Corrective Action Plan

Bill.com is the system being used to approve disbursements and maintain an audit trail.

Categories

Allowable Costs / Cost Principles Significant Deficiency Internal Control / Segregation of Duties

Other Findings in this Audit

  • 1221252 2024-004
    Material Weakness Repeat
  • 1221253 2024-005
    Material Weakness Repeat
  • 1221254 2024-006
    Material Weakness Repeat
  • 1221255 2024-007
    Material Weakness Repeat
  • 1221256 2024-008
    Material Weakness Repeat
  • 1221257 2024-009
    Material Weakness Repeat
  • 1221258 2024-004
    Material Weakness Repeat
  • 1221259 2024-005
    Material Weakness Repeat
  • 1221260 2024-006
    Material Weakness Repeat
  • 1221261 2024-007
    Material Weakness Repeat
  • 1221262 2024-008
    Material Weakness Repeat
  • 1221263 2024-009
    Material Weakness Repeat
  • 1221264 2024-004
    Material Weakness Repeat
  • 1221266 2024-006
    Material Weakness Repeat
  • 1221267 2024-007
    Material Weakness Repeat
  • 1221268 2024-008
    Material Weakness Repeat
  • 1221269 2024-009
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.959 Substance Abuse Prevention & Treatment Block Grant $106,407
93.959 Block Grants for Prevention and Treatment of Substance Abuse $92,707